| Literature DB >> 26418083 |
Ruth Chan1, Vincent Wai-Sun Wong2, Winnie Chiu-Wing Chu3, Grace Lai-Hung Wong2, Liz Sin Li4, Jason Leung5, Angel Mei-Ling Chim2, David Ka-Wai Yeung6, Mandy Man-Mei Sea1, Jean Woo1, Francis Ka-Leung Chan2, Henry Lik-Yuen Chan2.
Abstract
Dietary pattern analysis is an alternative approach to examine the association between diet and nonalcoholic fatty liver disease (NAFLD). This study examined the association of two diet-quality scores, namely Diet Quality Index-International (DQI-I) and Mediterranean Diet Score (MDS) with NAFLD prevalence. Apparently healthy Chinese adults (332 male, 465 female) aged 18 years or above were recruited through a population screening between 2008 and 2010 in a cross-sectional population-based study in Hong Kong. DQI-I and MDS, as well as major food group and nutrient intakes were calculated based on dietary data from a food frequency questionnaire. NAFLD was defined as intrahepatic triglyceride content at ≥5% by proton-magnetic resonance spectroscopy. Multivariate logistic regression models were used to examine the association between each diet-quality score or dietary component and prevalent NAFLD with adjustment for potential lifestyle, metabolic and genetic factors. A total of 220 subjects (27.6%) were diagnosed with NAFLD. DQI-I but not MDS was associated with the prevalence of NAFLD. A 10-unit decrease in DQI-I was associated with 24% increase in the likelihood of having NAFLD in the age and sex adjusted model (95% CI: 1.06-1.45, p = 0.009), and the association remained significant when the model was further adjusted for other lifestyle factors, metabolic and genetic factors [OR: 1.26 (95% CI: 1.03-1.54), p = 0.027]. Multivariate regression analyses showed an inverse association of the intake of vegetables and legumes, fruits and dried fruits, as well as vitamin C with the NAFLD prevalence (p<0.05). In conclusion, a better diet quality as characterized by a higher DQI-I and a higher consumption of vegetables, legumes and fruits was associated with a reduced likelihood of having NAFLD in Hong Kong Chinese.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26418083 PMCID: PMC4587971 DOI: 10.1371/journal.pone.0139310
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline subject characteristics between subjects with and without NAFLD (n = 797).
| No NAFLD (n = 577) | NAFLD (n = 220) |
| Age and sex adjusted | |
|---|---|---|---|---|
| Age (years) | 47.0 ± 10.8 | 51.0 + 9.3 | <0.001 | —- |
| BMI (kg/m2) | 21.7 ± 3.0 | 25.5 + 3.5 | <0.001 | <0.001 |
| WC (cm) | 78.4 ± 9.2 | 89.2 + 7.6 | <0.001 | <0.001 |
| Male [n (%)] | 214 (37.1) | 118 (53.6) | <0.001 | —- |
| Current smoker [n (%)] | 48 (8.3) | 19 (8.6) | 0.885 | 0.504 |
| Current drinker [n (%)] | 96 (16.6) | 55 (25.0) | 0.007 | 0.177 |
| MDS | 4.0 ± 1.7 | 4.0 + 1.8 | 0.904 | 0.068 |
| DQI-I | 57.9 ± 10.4 | 57.2 + 11.5 | 0.368 | 0.007 |
| SBP (mmHg) | 126.1 ± 19.0 | 137.8 + 19.0 | <0.001 | <0.001 |
| DBP (mmHg) | 79.2 ± 11.3 | 88.3 + 12.6 | <0.001 | <0.001 |
| Alanine aminotransferase (IU/l) | 19 (15–25) | 31 (23–42) | <0.001 | <0.001 |
| Fasting glucose (mmol/l) | 4.9 (4.6–5.2) | 5.2 (4.9–5.6) | <0.001 | <0.001 |
| Total cholesterol (mmol/l) | 5.1 + 1.0 | 5.4 + 1.0 | <0.001 | 0.012 |
| HDL-cholesterol (mmol/l) | 1.6 + 0.4 | 1.3 + 0.3 | <0.001 | <0.001 |
| Triglycerides (mmol/l) | 0.9 (0.7–1.2) | 1.6 (1.2–2.3) | <0.001 | <0.001 |
| LDL-cholesterol (mmol/l) | 2.9 ± 0.8 | 3.2 + 0.9 | <0.001 | 0.002 |
| Central obesity | 160 (27.7) | 143 (65.0) | <0.001 | <0.001 |
| Triglycerides > 1.7 mmol/l | 63 (10.9) | 97 (44.1) | <0.001 | <0.001 |
| Reduced HDL-cholesterol | 45 (7.8) | 64 (29.1) | <0.001 | <0.001 |
| Hypertension | 251 (43.5) | 161 (73.2) | <0.001 | <0.001 |
| Impaired fasting glucose or DM | 53 (9.2) | 61 (27.7) | <0.001 | <0.001 |
| Metabolic syndrome | 45 (7.8) | 105 (47.7) | <0.001 | <0.001 |
|
| ||||
| CC | 248 (43.1) | 63 (28.6) | <0.001 | <0.001 |
| CG | 265 (46.0) | 115 (52.3) | ||
| GG | 63 (10.9) | 42 (19.1) | ||
| Intrahepatic triglyceride content (%) | 1.2 (0.7–2.4) | 9.8 (7.0–15.4) | <0.001 | <0.001 |
1 Group difference by independent t test for continuous variables and chi-squared or Fisher exact test for categorical variables unless otherwise stated
2 Group difference by ANCOVA for continuous variables and logistic regression for categorical variables unless otherwise stated
3 Mean ± SD or median (interquarter range) (all such values) unless otherwise stated
4 Group difference by nonparametric Mann-Whiney U test
5 International Diabetes Federation criteria for metabolic syndrome [38]
BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score; NAFLD, nonalcoholic fatty liver disease; SBP, systolic blood pressure; WC, waist circumference
Correlation between each diet-quality score and selected food group and nutrient intakes (n = 797).
| Daily food group/nutrient intake | MDS |
| DQI-I |
|
|---|---|---|---|---|
| Beverages (ml) | -0.157 | <0.001 | -0.198 | <0.001 |
| Dim sum (g) | -0.015 | 0.671 | -0.033 | 0.353 |
| Eggs (g) | -0.097 | 0.006 | -0.207 | <0.001 |
| Fast food (g) | -0.219 | <0.001 | -0.185 | <0.001 |
| Meat, poultry and organ meats (g) | -0.242 | <0.001 | -0.281 | <0.001 |
| Fish and seafood (g) | 0.394 | <0.001 | 0.151 | <0.001 |
| Fruits (g) | 0.508 | <0.001 | 0.604 | <0.001 |
| Grains and cereals (g) | 0.344 | <0.001 | 0.379 | <0.001 |
| Mushroom, fungi and nuts (g) | 0.231 | <0.001 | 0.177 | <0.001 |
| Soy and soy products (g) | 0.350 | <0.001 | 0.235 | <0.001 |
| Vegetables and legumes (g) | 0.512 | <0.001 | 0.539 | <0.001 |
| Milk and milk products (g) | -0.301 | <0.001 | 0.009 | 0.800 |
| Tea and coffee (ml) | 0.030 | 0.397 | -0.016 | 0.642 |
| % energy from carbohydrate | 0.321 | <0.001 | 0.651 | <0.001 |
| % energy from protein | 0.024 | 0.505 | -0.022 | 0.539 |
| % energy from total fat | -0.311 | <0.001 | -0.664 | <0.001 |
| % energy from saturated fat | -0.473 | <0.001 | -0.634 | <0.001 |
| Cholesterol (mg) | -0.045 | 0.201 | -0.220 | <0.001 |
| Dietary fiber (g) | 0.544 | <0.001 | 0.642 | <0.001 |
| Vitamin C (mg) | 0.502 | <0.001 | 0.615 | <0.001 |
1 Spearman’s rank correlation was used for food group intake analysis and vitamin C intake analysis whereas Pearson’s correlation was used for other nutrient intakes analysis
2 Included mainly sweetened beverages or juice, carbonated drinks and sports drinks
DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score
Linear regression analysis linking each diet-quality score and the intrahepatic triglyceride content (n = 797).
| Diet-quality score | Age and sex adjusted | Multivariate adjusted | ||||
|---|---|---|---|---|---|---|
| Beta | SE |
| Beta | SE |
| |
| MDS | -0.036 | 0.011 | 0.001 | -0.033 | 0.009 | <0.001 |
| DQI-I | -0.006 | 0.002 | 0.001 | -0.004 | 0.001 | 0.003 |
1 Logarithmic transformation was applied for regression analysis
2 Further adjusted for BMI, energy intake, current smoker status (yes/no), current drinker status (yes/no), central obesity (yes/no), triglyceride >1.7 mmol/l (yes/no), reduced HDL-cholesterol (yes/no), hypertension (yes/no), impaired fasting glucose or diabetes (yes/no), and the PNPLA3 genotypes (CC vs. CG vs. GG genotypes)
DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score
Overall and stratified logistic regression analysis linking each diet-quality score and the presence of NAFLD (n = 797).
| No. of | MDS (per 1 unit decrease) | DQI-I (per 10 unit decrease) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAFLD | Age and sex adjusted | Multivariate adjusted | Age and sex adjusted | Multivariate adjusted | |||||||||
| case/control | OR | 95% CI |
| OR | 95% CI |
| OR | 95% CI |
| OR | 95% CI |
| |
| Overall analysis | 220/577 | 1.10 | 0.99–1.21 | 0.073 | 1.11 | 0.98–1.26 | 0.092 | 1.24 | 1.06–1.45 |
| 1.26 | 1.03–1.54 |
|
| Stratified analysis | |||||||||||||
| Sex | |||||||||||||
| Male | 118/214 | 1.09 | 0.95–1.25 | 0.244 | 1.17 | 0.98–1.38 | 0.081 | 1.30 | 1.06–1.61 |
| 1.34 | 1.03–1.75 |
|
| Female | 102/363 | 1.12 | 0.97–1.29 | 0.111 | 1.01 | 0.85–1.21 | 0.901 | 1.20 | 0.95–1.52 | 0.134 | 1.09 | 0.80–1.47 | 0.588 |
| Age | |||||||||||||
| <50 years | 92/317 | 1.07 | 0.92–1.24 | 0.401 | 1.10 | 0.90–1.33 | 0.363 | 1.22 | 0.97–1.55 | 0.091 | 1.23 | 0.90–1.68 | 0.202 |
| > = 50 years | 128/260 | 1.04 | 0.92–1.18 | 0.497 | 1.05 | 0.90–1.23 | 0.525 | 1.15 | 0.94–1.41 | 0.188 | 1.11 | 0.86–1.44 | 0.410 |
| BMI status | |||||||||||||
| <23 kg/m2 | 53/426 | 1.00 | 0.83–1.21 | 0.975 | 1.01 | 0.81–1.28 | 0.903 | 1.05 | 0.79–1.39 | 0.739 | 0.88 | 0.62–1.25 | 0.480 |
| > = 23 kg/m2 | 167/147 | 1.16 | 1.01–1.33 |
| 1.19 | 1.03–1.38 |
| 1.29 | 1.04–1.61 |
| 1.39 | 1.09–1.77 |
|
| Current drinker | |||||||||||||
| Yes | 55/96 | 1.20 | 0.97–1.48 | 0.089 | 1.28 | 0.97–1.69 | 0.086 | 1.14 | 0.84–1.56 | 0.394 | 1.31 | 0.85–2.03 | 0.219 |
| No | 165/481 | 1.06 | 0.95–1.19 | 0.313 | 1.05 | 0.91–1.20 | 0.511 | 1.25 | 1.04–1.51 |
| 1.17 | 0.93–1.47 | 0.174 |
| Metabolic syndrome | |||||||||||||
| Yes | 105/45 | 1.09 | 0.88–1.34 | 0.437 | 1.12 | 0.88–1.42 | 0.351 | 1.11 | 0.81–1.53 | 0.524 | 1.22 | 0.84–1.78 | 0.288 |
| No | 115/532 | 1.06 | 0.94–1.21 | 0.345 | 1.06 | 0.91–1.22 | 0.467 | 1.22 | 0.99–1.50 | 0.059 | 1.20 | 0.94–1.53 | 0.142 |
|
| |||||||||||||
| CC | 63/248 | 1.23 | 1.02–1.49 |
| 1.17 | 0.93–1.47 | 0.192 | 1.31 | 0.98–1.76 | 0.073 | 1.30 | 0.90–1.88 | 0.156 |
| CG | 115/265 | 1.06 | 0.92–1.22 | 0.445 | 1.07 | 0.89–1.28 | 0.469 | 1.27 | 1.02–1.59 | 0.031 | 1.22 | 0.92–1.62 | 0.176 |
| GG | 42/63 | 1.08 | 0.87–1.34 | 0.479 | 1.16 | 0.86–1.57 | 0.330 | 1.15 | 0.78–1.68 | 0.482 | 1.16 | 0.67–2.02 | 0.600 |
1 Adjusted for age and sex, expect for the stratified variable whenever appropriate.
2 Further adjusted for BMI, energy intake, current smoker status (yes/no), current drinker status (yes/no), central obesity (yes/no), triglyceride >1.7 mmol/l (yes/no), reduced HDL-cholesterol (yes/no), hypertension (yes/no), impaired fasting glucose or diabetes (yes/no), and the PNPLA3 genotypes (CC vs. CG vs. GG genotypes), except for the stratified variable whenever appropriate.
DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score; NAFLD, non-alcoholic fatty liver disease
Logistic regression analysis linking individual food groups or nutrients and the presence of NAFLD (n = 797).
| Food group/nutrient | Tertile | No. of | Age and sex adjusted | Multivariate adjusted | ||||
|---|---|---|---|---|---|---|---|---|
| NAFLD | OR | 95% CI |
| OR | 95% CI |
| ||
| case/control |
|
| ||||||
| Beverages (ml) | 0 | 231/87 | 1 |
| 1 | 0.091 | ||
| 1–71 | 163/47 | 1.01 | 0.66–1.54 | 1.22 | 0.72–2.08 | |||
| 71+ | 183/86 | 1.68 | 1.14–2.47 | 1.53 | 0.93–2.52 | |||
| Dim sum (g) | <14 | 202/76 | 1 | 0.551 | 1 | 0.548 | ||
| 14–40 | 188/67 | 1.07 | 0.72–1.59 | 1.06 | 0.64–1.75 | |||
| 40+ | 187/77 | 1.13 | 0.76–1.65 | 1.16 | 0.71–1.89 | |||
| Egg and egg products (g) | <7 | 209/79 | 1 | 0.754 | 1 | 0.471 | ||
| 7–21 | 150/57 | 1.00 | 0.66–1.51 | 0.81 | 0.48–1.34 | |||
| 21+ | 218/84 | 1.06 | 0.73–1.54 | 0.84 | 0.52–1.36 | |||
| Fast food (g) | 0 | 343/135 | 1 | 0.387 | 1 | 0.588 | ||
| 1+ | 234/85 | 1.16 | 0.83–1.63 | 1.13 | 0.74–1.72 | |||
| Meat, poultry and organ meats (g) | <91 | 197/68 | 1 | 0.107 | 1 | 0.368 | ||
| 91–150 | 199/68 | 1.05 | 0.70–1.58 | 1.30 | 0.78–2.17 | |||
| 150+ | 181/84 | 1.39 | 0.93–2.09 | 1.30 | 0.73–2.32 | |||
| Fish and seafood (g) | <43 | 189/76 | 1 | 0.911 | 1 | 0.991 | ||
| 43–85 | 205/62 | 0.78 | 0.52–1.16 | 0.88 | 0.53–1.46 | |||
| 85+ | 183/82 | 1.02 | 0.70–1.50 | 1.00 | 0.61–1.64 | |||
| Fruits and dried fruits (g) | <132 | 185/80 | 1 |
| 1 |
| ||
| 132–229 | 195/71 | 0.73 | 0.50–1.09 | 0.70 | 0.43–1.16 | |||
| 229+ | 197/69 | 0.57 | 0.38–0.86 | 0.50 | 0.30–0.84 | |||
| Grains and cereals (g) | <444 | 194/72 | 1 | 0.173 | 1 | 0.134 | ||
| 444–637 | 196/69 | 0.80 | 0.53–1.19 | 0.85 | 0.50–1.42 | |||
| 637+ | 187/79 | 0.75 | 0.49–1.14 | 0.64 | 0.36–1.15 | |||
| Mushroom, fungi and nuts (g) | <2 | 183/84 | 1 |
| 1 | 0.168 | ||
| 2–13 | 189/71 | 0.79 | 0.54–1.16 | 0.83 | 0.50–1.36 | |||
| 13+ | 205/65 | 0.66 | 0.44–0.98 | 0.70 | 0.42–1.16 | |||
| Soy and soy products (g) | <12 | 193/73 | 1 | 0.731 | 1 | 0.550 | ||
| 12–54 | 188/77 | 1.05 | 0.71–1.55 | 1.15 | 0.70–1.89 | |||
| 54+ | 196/70 | 0.93 | 0.63–1.38 | 0.86 | 0.52–1.42 | |||
| Vegetables and legumes (g) | <119 | 185/80 | 1 |
| 1 |
| ||
| 119–207 | 190/76 | 0.86 | 0.58–1.27 | 0.79 | 0.48–1.29 | |||
| 207+ | 202/64 | 0.58 | 0.38–0.87 | 0.51 | 0.30–0.87 | |||
| Milk and milk products (g) | <4 | 179/80 | 1 | 0.054 | 1 | 0.624 | ||
| 4–30 | 193/83 | 1.08 | 0.74–1.58 | 1.53 | 0.94–2.49 | |||
| 30+ | 205/57 | 0.67 | 0.45–1.01 | 1.14 | 0.68–1.91 | |||
| Tea and coffee (ml) | <179 | 194/64 | 1 | 0.166 | 1 | 0.671 | ||
| 179–464 | 209/65 | 0.83 | 0.55–1.24 | 0.58 | 0.34–0.97 | |||
| 464+ | 174/91 | 1.32 | 0.89–1.96 | 1.12 | 0.68–1.84 | |||
| % energy from carbohydrate | —- | —- | 0.98 | 0.96–1.00 |
| 0.98 | 0.95–1.00 | 0.067 |
| % energy from protein | —- | —- | 1.03 | 0.98–1.08 | 0.211 | 1.00 | 0.95–1.06 | 0.921 |
| % energy from total fat | —- | —- | 1.02 | 1.00–1.04 | 0.130 | 1.03 | 1.00–1.06 | 0.089 |
| % energy from saturated fat | —- | —- | 1.03 | 0.95–1.13 | 0.436 | 1.02 | 0.92–1.14 | 0.714 |
| Cholesterol (mg) | —- | —- | 1.00 | 0.99–1.00 | 0.275 | 1.00 | 0.99–1.00 | 0.963 |
| Dietary fiber (g) | —- | —- | 0.97 | 0.94–1.00 |
| 0.96 | 0.93–1.00 | 0.054 |
| Vitamin C (mg) | —- | —- | 0.40 | 0.19–0.85 |
| 0.36 | 0.14–0.89 |
|
1 Tertiles based on the distribution of all subjects, except two categories for the fast food intake (intake = 0 vs. intake > 0 g per day)
2 Further adjusted for BMI, current smoker status (yes/no), current drinker status (yes/no), central obesity (yes/no), triglyceride >1.7 mmol/l (yes/no), reduced HDL-cholesterol (yes/no), hypertension (yes/no), impaired fasting glucose or diabetes (yes/no), and the PNPLA3 genotypes (CC vs. CG vs. GG genotypes). Energy intake was further adjusted in the multivariate model of food group intake analysis.
3 P was examined by entering tertiles of food group intake as a fixed factor for the models of food group intake analysis, whereas P value was used for the models of nutrient intake analysis.
4 Included mainly sweetened beverages or juice, carbonated drinks and sports drinks
NAFLD, non-alcoholic fatty liver disease